Covid-19 vaccines: In the rush for regulatory approval, do we need more data?
PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionPeter Doshi questions the rush to seek FDA approval for the COVID-19 vaccines currently being administered under the FDA's "Emergency Use Authorization"
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15669